Arylsulfonylimidazolone derivatives as an antitumor agent

Details Arylsulfonylimidazolone derivatives as an antitumor agent Arylsulfonylimidazolone derivatives as an antitumor agent

C - Chemistry, Metallurgy

07

D

C07D 403/12 (2006.01) A61K 31/415 (2006.01) A61K 31/44 (2006.01) C07D 401/14 (2006.01) C07D 403/14 (2006.01) C07D 405/14 (2006.01) C07D 409/14 (2006.01)

Patent

CA 2263353

The present invention relates to a novel arylsulfonylimidazolone derivative represented by formula (I) which shows a superior antineoplastic activity in contrast to the known sulfonylurea antitumor agents as well as little side effect; and its pharmaceutically acceptable salt and stereoisomer, in which <u>--</u>, R1 and R2 are as defined in the specification.

L'invention se rapporte à un nouveau dérivé d'arylsulfonylimidazoline qui répond à la formule suivante (I) où <u>--</u>, R¿1? et R¿2? sont tels qu'ils sont définis dans la description, et qui possède une action antinéoplastique supérieure à celle des agents anti-tumoraux connus à base de sulfonylurée tout en ayant peu d'effets secondaires; l'invention se rapporte également à un sel pharmaceutiquement acceptable et à un stéréo-isomère dudit dérivé.

Affiliated with

Also associated with

Rating

Arylsulfonylimidazolone derivatives as an antitumor agent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylsulfonylimidazolone derivatives as an antitumor agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonylimidazolone derivatives as an antitumor agent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-2045721